BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-13 out of 13 found
  Current Search:  amitiza: 13     

HTML
100%
Sucampo Seeks To Terminate Amitiza Marketing Agreement With Takeda
Remember Me Already a subscriber?

Sign in or register to create an account?

Search Include Synonyms PUBLICATIONS: Check All | Uncheck All 'The Pink Sheet' 'The Rose Sheet' Pharmaceutical Approvals Monthly 'The Gold Sheet' 'The Gray Sheet' Health News Daily ...

The Pink Sheet:  Mar 19 2010 10:12AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals blames partner for low sales of key drug
Sucampo Pharmaceuticals Inc.

said its bank balance is short by hundreds of millions of dollars it expected to earn during the last several years and contends that another company is to blame.

The Bethesda biotech has retaliated against its Tokyo-based...

Washington Business Journal:  Mar 19 2010 5:28PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Reports Full Year and Fourth Quarter 2009 Financial Results
- Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today reported its consolidated financial results for the fourth quarter and year ended December 31, 2009, outlined key highlights for 2010 and reported that it filed a demand for arbitration of its agreement...

Pharma Live:  Mar 16 2010 5:58PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Reports Full Year and Fourth Quarter 2009 Financial Results
BETHESDA, Md.(BUSINESS WIRE) Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today reported its consolidated financial results for the fourth quarter and year ended December 31, 2009, outlined key highlights for 2010 and reported that it filed a demand for...

Your Story:  Mar 16 2010 9:51AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Reports Full Year and Fourth Quarter 2009 Financial Results
BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today reported its consolidated financial results for the fourth quarter and year ended December 31, 2009, outlined key highlights for 2010 and reported that it filed a demand for...

Yahoo! Canada:  Mar 16 2010 1:05AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Reports Full Year and Fourth Quarter 2009 Financial Results
Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today reported its consolidated financial results for the fourth quarter and year ended December 31, 2009, outlined key highlights for 2010 and reported that it filed a demand for arbitration of its agreement with...

Genetic Engineering News:  Mar 15 2010 11:29PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Reports Full Year and Fourth Quarter 2009 Financial Results
Companies mentioned in this article: Sucampo Pharmaceuticals, Inc.

BETHESDA, Md.

-- (BUSINESS WIRE) -- Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today reported its consolidated financial results for the fourth quarter and year ended December 31, 2009,...

Freshnews.com:  Mar 15 2010 9:40PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo to Release Fourth Quarter and Full Year 2009 Financial Results and Conduct a Conference Call on March 15, 2010
BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today announced that it will sponsor a conference call to discuss its financial results for the fourth quarter and full year ended December 31, 2009.

These results are expected to...

Yahoo! Canada:  Mar 2 2010 5:21PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo to Release Fourth Quarter and Full Year 2009 Financial Results and Conduct a Conference Call on March 15, 2010
Companies mentioned in this article: Sucampo Pharmaceuticals, Inc.

BETHESDA, Md.

-- (BUSINESS WIRE) -- Sucampo Pharmaceuticals, Inc.

(NASDAQ:SCMP) today announced that it will sponsor a conference call to discuss its financial results for the fourth...

Freshnews.com:  Mar 2 2010 2:08PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo to Release Fourth Quarter and Full Year 2009 Financial Results and Conduct a Conference Call on March
8:15 AM EST News source: Business Wire Sucampo Pharmaceuticals, Inc.

(NASDAQ:SCMP) today announced that it will sponsor a conference call to discuss its financial results for the fourth quarter and full year ended December 31, 2009.

These results are...

Genetic Engineering News:  Mar 2 2010 2:49PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Appoints Thomas J. Knapp as Senior Vice President, General Counsel and Corporate Secretary
- Sucampo Pharmaceuticals, Inc.

(NASDAQ:SCMP) today announced the appointment of Thomas J.

Knapp as Senior Vice President, General Counsel and Corporate Secretary, a newly-created position, effective February 19, 2010, reporting to James J.

Egan, Chief...

Pharma Live:  Feb 26 2010 3:28AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Appoints Thomas J. Knapp as Senior Vice President, General Counsel and Corporate Secretary
BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today announced the appointment of Thomas J.

Knapp as Senior Vice President, General Counsel and Corporate Secretary, a newly-created position, effective February 19, 2010,...

Yahoo! Canada:  Feb 26 2010 12:19AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Appoints Thomas J. Knapp as Senior Vice President, General Counsel and Corporate Secretary
Sucampo Pharmaceuticals, Inc.

(NASDAQ:SCMP) today announced the appointment of Thomas J.

Knapp as Senior Vice President, General Counsel and Corporate Secretary, a newly-created position, effective February 19, 2010, reporting to James J.

Egan, Chief...

Genetic Engineering News:  Feb 25 2010 11:39PM
Matching: amitiza
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.